前列腺癌嘅預後係點呢?
前列腺癌嘅預測取決於幾種因素,包括癌症嘅階段,病人嘅年齡同一般健康狀況,同埋癌細胞嘅侵略性.
一般嚟講,前列腺癌嘅預後係好嘅 尤其當佢早期被發現嘅時候
局部性前列腺癌 (未擴散到前列腺之外嘅癌症) 嘅五年存活率差唔多係 100% 但係,隨著癌症發展同擴散到身體其他部位,預測會變得更差.
同醫療專業人士討論特定嘅預測係重要嘅,因為預測可以因人而異.
前列腺癌嘅預測取決於幾種因素,包括癌症嘅階段,病人嘅年齡同一般健康狀況,同埋癌細胞嘅侵略性.
一般嚟講,前列腺癌嘅預後係好嘅 尤其當佢早期被發現嘅時候
局部性前列腺癌 (未擴散到前列腺之外嘅癌症) 嘅五年存活率差唔多係 100% 但係,隨著癌症發展同擴散到身體其他部位,預測會變得更差.
同醫療專業人士討論特定嘅預測係重要嘅,因為預測可以因人而異.
PubMed/Medline https://www.nlm.nih.gov/databases/download/pubmed_medline.html
RefinedWeb https://arxiv.org/abs/2306.01116
Yang X, Wang R, Xu K, Yang F, Chen Y, Zuo Z, Song B: [Knockdown of myeloid cell leukemia 1 gene inhibits the proliferation and promotes apoptosis of prostate cancer cells]. Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi. 2017, 33 (1): 62-66.
Kubota Y, Ito K, Imai K, Yamanaka H: Effectiveness of mass screening for the prognosis of prostate cancer patients in Japanese communities. Prostate. 2002, 50 (4): 262-9.
Li K, Zhou H, Wang F, Zhao C, Fan C, Wang J: ZBTB38 suppresses prostate cancer cell proliferation and migration via directly promoting DKK1 expression. Cell Death Dis. 2021, 12 (11): 998.
Sun HF, Wang WD, Feng L: Effect of SPAG9 on migration, invasion and prognosis of prostate cancer. Int J Clin Exp Pathol. 2017, 10 (9): 9468-9474.
Xia Q, Li J, Yang Z, Zhang D, Tian J, Gu B: Long non-coding RNA small nucleolar RNA host gene 7 expression level in prostate cancer tissues predicts the prognosis of patients with prostate cancer. Medicine (Baltimore). 2020, 99 (7): e18993.
Dong L, Ding H, Li Y, Xue D, Li Z, Liu Y, Zhang T, Zhou J, Wang P: TRIP13 is a predictor for poor prognosis and regulates cell proliferation, migration and invasion in prostate cancer. Int J Biol Macromol. 2019, 121 (): 200-206.
Rucci N, Angelucci A: Prostate cancer and bone: the elective affinities. Biomed Res Int. 2014, 2014 (): 167035.
呢個網站只為教育同資訊目的而設,並唔係提供醫療建議或者專業服務.
提供嘅信息唔應該用嚟診斷或者治療健康問題或者疾病, 而尋求個人醫學意見嘅人應該同有執照嘅醫生諮詢.
請留意,生成答案嘅神經網絡 尤其喺數字內容方面係唔準確嘅 譬如,有幾多人被診斷有一種特定嘅疾病
如果你認為你可能有醫療緊急情況,請立即打電話俾 911 或者去最近嘅急救室. 冇醫生同病人之間嘅關係係由呢個網站或者使用呢個網站所造成嘅. BioMedLib 或者佢嘅員工,或者呢個網站嘅任何貢獻者, 都唔會明確或者暗示地對呢個網站提供嘅信息或者使用呢個網站.
1998 年嘅"數碼千年版權法" (Digital Millennium Copyright Act) 17 U.S.C. § 512 (
如果你真心相信我哋網站或者服務提供嘅任何內容或者材料 侵犯咗你嘅版權,你 (或者你嘅代理人) 可以寄畀我哋一個通知,要求刪除內容或者材料,或者阻止對內容或者材料嘅接觸.
通知必須以書面形式通過電子郵件發送 (電子郵件地址請見"聯絡人"部分).
DMCA 要求您的版权侵犯通知包括以下信息: (1) 描述被指控侵犯的受版权保护的作品; (2) 描述被指控侵犯的内容和足够的信息,使我们能够找到内容; (3) 您的联系信息,包括您的地址,电话号码和电子邮件地址; (4) 您的声明,您有诚信的信念,认为所投诉的方式的内容未被版权所有者或其代理人或任何法律授权;
(5) 你簽署嘅聲明,以免犯錯誓罪,證明通知中嘅信息係正確嘅,同埋你有權執行被聲稱被侵犯嘅版權;
(6) 版權所有者或者被授權代表版權所有者行動嘅人嘅實體或電子簽名.
如果您唔包括上述所有信息,可能會導致您的投訴被延遲處理.
請將任何問題/建議發到電子郵件.
The prognosis of prostate cancer depends on several factors, including the stage of the cancer, the patient's age and overall health, and the aggressiveness of the cancer cells.
In general, prostate cancer has a good prognosis, especially when caught early.
The 5-year survival rate for localized prostate cancer (cancer that has not spread beyond the prostate) is nearly 100%. However, the prognosis worsens as the cancer progresses and spreads to other parts of the body.
It is important to discuss the specific prognosis with a healthcare professional, as it can vary greatly from person to person.
This web site is provided for educational and informational purposes only and does not constitute providing medical advice or professional services.
The information provided should not be used for diagnosing or treating a health problem or disease, and those seeking personal medical advice should consult with a licensed physician.
Please note the neural net that generates answers to the questions, is specially inaccurate when it comes to numeric content. For example, the number of people diagnosed with a specific disease.
Always seek the advice of your doctor or other qualified health provider regarding a medical condition. Never disregard professional medical advice or delay in seeking it because of something you have read on this website. If you think you may have a medical emergency, call 911 or go to the nearest emergency room immediately. No physician-patient relationship is created by this web site or its use. Neither BioMedLib nor its employees, nor any contributor to this web site, makes any representations, express or implied, with respect to the information provided herein or to its use.
The Digital Millennium Copyright Act of 1998, 17 U.S.C. § 512 (the “DMCA”) provides recourse for copyright owners who believe that material appearing on the Internet infringes their rights under U.S. copyright law. If you believe in good faith that any content or material made available in connection with our website or services infringes your copyright, you (or your agent) may send us a notice requesting that the content or material be removed, or access to it blocked. Notices must be sent in writing by email (see 'Contact' section for email address) . The DMCA requires that your notice of alleged copyright infringement include the following information: (1) description of the copyrighted work that is the subject of claimed infringement; (2) description of the alleged infringing content and information sufficient to permit us to locate the content; (3) contact information for you, including your address, telephone number and email address; (4) a statement by you that you have a good faith belief that the content in the manner complained of is not authorized by the copyright owner, or its agent, or by the operation of any law; (5) a statement by you, signed under penalty of perjury, that the information in the notification is accurate and that you have the authority to enforce the copyrights that are claimed to be infringed; and (6) a physical or electronic signature of the copyright owner or a person authorized to act on the copyright owner’s behalf. Failure to include all of the above information may result in the delay of the processing of your complaint.
BioMedLib 用自動化電腦 (機器學習算法) 生成問題同答案對.
我哋從PubMed/Medline 嘅三千五百萬份生物醫學出版物 開始 我哋亦從RefinedWeb 嘅網頁開始
睇下"參考"同"免責聲明".